Oak Street Health, Inc. (NYSE:OSH) COO Sells $312,750.00 in Stock

Oak Street Health, Inc. (NYSE:OSH) COO Geoffrey M. Price sold 12,500 shares of the firm’s stock in a transaction dated Tuesday, January 11th. The stock was sold at an average price of $25.02, for a total value of $312,750.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of OSH stock opened at $22.00 on Friday. The stock has a 50 day moving average of $32.75 and a 200 day moving average of $44.62. The company has a current ratio of 2.78, a quick ratio of 2.78 and a debt-to-equity ratio of 5.88. The stock has a market cap of $5.30 billion, a P/E ratio of -13.58 and a beta of 1.14. Oak Street Health, Inc. has a twelve month low of $21.56 and a twelve month high of $66.31.

Oak Street Health (NYSE:OSH) last announced its quarterly earnings results on Monday, November 8th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The company had revenue of $388.70 million for the quarter, compared to analysts’ expectations of $357.53 million. Oak Street Health had a negative net margin of 27.80% and a negative return on equity of 133.13%. The firm’s revenue was up 78.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.15) earnings per share. On average, research analysts predict that Oak Street Health, Inc. will post -1.83 earnings per share for the current fiscal year.

Several equities research analysts have weighed in on the company. Truist lowered their price target on Oak Street Health from $72.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, October 13th. Piper Sandler lowered their price target on Oak Street Health from $55.00 to $47.00 in a report on Tuesday. Truist Securities lowered their price target on Oak Street Health from $72.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, October 13th. Cowen downgraded Oak Street Health from an “outperform” rating to a “market perform” rating and lowered their price target for the stock from $48.00 to $25.00 in a report on Monday, January 10th. Finally, SVB Leerink lowered their price target on Oak Street Health from $51.00 to $41.00 and set a “market perform” rating for the company in a report on Wednesday, November 10th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $57.82.

A number of hedge funds have recently made changes to their positions in OSH. Victory Capital Management Inc. raised its position in Oak Street Health by 150.1% during the second quarter. Victory Capital Management Inc. now owns 13,658 shares of the company’s stock valued at $800,000 after acquiring an additional 8,196 shares in the last quarter. Envestnet Asset Management Inc. raised its position in Oak Street Health by 39.2% during the second quarter. Envestnet Asset Management Inc. now owns 10,464 shares of the company’s stock valued at $613,000 after acquiring an additional 2,947 shares in the last quarter. Rhumbline Advisers raised its position in Oak Street Health by 17.4% during the second quarter. Rhumbline Advisers now owns 93,587 shares of the company’s stock valued at $5,481,000 after acquiring an additional 13,863 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Oak Street Health by 21,572.7% in the second quarter. PNC Financial Services Group Inc. now owns 2,384 shares of the company’s stock valued at $140,000 after buying an additional 2,373 shares in the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp purchased a new stake in shares of Oak Street Health in the second quarter valued at approximately $1,052,000. Institutional investors own 85.67% of the company’s stock.

Oak Street Health Company Profile

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.

Featured Article: Beige Book

Insider Buying and Selling by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.